v3.25.2
Consolidated Statements Of Operations - USD ($)
shares in Thousands, $ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Income Statement [Abstract]        
Net sales $ 5,208 $ 5,051 $ 10,033 $ 9,952
Operating expenses:        
Cost of sales 4,211 4,083 8,116 8,106
Selling, general and administrative 406 405 790 771
Amortization 53 52 104 106
Restructuring (Note 7) 52 70 89 109
Total operating expenses 4,722 4,610 9,099 9,092
Operating income 486 441 934 860
Interest expense (91) (64) (184) (129)
Other income, net 12 10 12 25
Net gain on equity method transactions 46 641 46 641
Income before income taxes and equity loss 453 1,028 808 1,397
Income tax (expense) benefit (45) (51) (401) (127)
Income before equity loss 408 977 407 1,270
Equity loss, net of tax (11) (34) (21) (103)
Net income 397 943 386 1,167
Net income attributable to noncontrolling interest 5 5 6 11
Net loss attributable to redeemable noncontrolling interest (1) 0 (2) 0
Net income attributable to Aptiv $ 393 $ 938 $ 382 $ 1,156
Basic net income per share:        
Basic net income per share attributable to ordinary shareholders $ 1.80 $ 3.47 $ 1.71 $ 4.24
Weighted average number of basic shares outstanding 217,730 270,190 223,910 272,690
Diluted net income per share (Note 12):        
Diluted net income per share attributable to ordinary shareholders $ 1.80 $ 3.47 $ 1.70 $ 4.24
Weighted average number of diluted shares outstanding 218,110 270,430 224,320 272,870